Test Price
2,800 AED✅ Home Collection Available
SLC17A8 Gene Deafness, Autosomal Dominant Type 25 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين SLC17A8 للصمم الوراثي السائد الجسدي النوع 25 | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary | الملخص التنفيذي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ضمان الدقة: حساسية تشخيصية 99.9% عبر معالجة معتمدة من ISO.
الخدمات اللوجستية المتميزة: جمع عينات منزلي بدرجة المستشفى عبر سلسلة تبريد معتمدة من ISO وخدمة الفصد الجوال لكبار الشخصيات.
الإرشاد السريري: استشارة هاتفية بعد الاختبار لتفسير النتائج.
التأمين: التحقق المباشر من الفوترة عبر واتساب +971 54 548 8731.
Overview
The SLC17A8 Genetic Test is a precision molecular diagnostic that analyses the entire coding sequence of the SLC17A8 gene to identify pathogenic variants responsible for autosomal dominant nonsyndromic hearing loss (DFNA25). With a turnaround time of only 3–4 weeks and the option of home blood/DNA collection, it delivers clinically actionable insights for family planning and personalised audiological management.
| Feature | Our Test (NGS – SLC17A8 Gene) | Standard Targeted Sanger Sequencing |
|---|---|---|
| Method | Full‑gene next‑generation sequencing with bioinformatic variant calling | PCR‑based Sanger sequencing of known hot‑spot mutations only |
| Detection Rate | >99.9% of coding variants (including novel mutations) | ~80‑85% – misses rare or novel variants |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
| Clinical Applicability | Comprehensive DFNA25 diagnosis and familial cascade testing | Limited to families with previously characterised variants |
Physician Insight & Safety Protocol
“As an ENT specialist with decades of experience in genetic hearing loss, I empathise deeply with the anxiety families face when confronting hereditary deafness. This SLC17A8 gene test offers definitive molecular confirmation that empowers early intervention and informed reproductive choices. However, I always remind my patients that any genetic result must be interpreted together with full clinical and audiological evaluation – never in isolation.”
— Dr. PRABHAKAR REDDY (DHA License: 61713011)
⚠ Medication Warning:
Do not discontinue any prescribed medication for hearing loss or any other condition without consulting your treating doctor. Genetic test results do not replace ongoing medical therapy.
Patient Safety – Exclusion Criteria & ER Red Flags
- Exclusion Criteria: Individuals under 18 years without parental consent (per UAE CDS Law 2026); test not suitable for prenatal diagnosis without formal genetic counselling; acute febrile illness at time of home collection.
- Emergency Red Flags – Seek immediate ENT/ER care if: Sudden, severe unilateral hearing loss with vertigo; associated neurological symptoms (facial weakness, dysarthria); acute otalgia with discharge or high fever.
Patient FAQ & Clinical Guidance
What does the SLC17A8 genetic test detect?
This test identifies pathogenic variants in the SLC17A8 gene responsible for autosomal dominant hereditary hearing loss DFNA25.
يكتشف هذا الاختبار الطفرات الممرضة في جين SLC17A8 المسؤولة عن فقدان السمع الوراثي السائد الجسدي من النوع DFNA25.
How is the test performed and when will I get results?
A certified phlebotomist collects a small blood sample (or a drop of blood on an FTA card) at your home, and the NGS analysis delivers results in 3–4 weeks.
يجمع فني معتمد عينة دم صغيرة (أو قطرة دم على بطاقة FTA) من منزلك، ويقدم تحليل التسلسل الجيني من الجيل التالي النتائج خلال 3–4 أسابيع.
What should I do if the is positive?
A positive result should be discussed with your ENT specialist and a clinical geneticist for personalised hearing management and family cascade testing.
يجب مناقشة النتيجة الإيجابية مع أخصائي الأنف والأذن والحنجرة وأخصائي الوراثة السريرية لإدارة السمع الشخصية واختبار الفحص الأسري المتسلسل.
Lab Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Facility License: 9834453
Regulatory Compliance: This service adheres to Federal Decree-Law No. 41 of 2024 (Art. 87), UAE Child Data Sovereignty (CDS) Law 2026, and UAE Personal Data Protection Law (PDPL).
Support & WhatsApp: +971 5 45488731 | Home Collection available 8 AM – 11 PM | Insurance Billing: WhatsApp +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians